• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of breast cancer.

作者信息

Hortobagyi G N

机构信息

Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

出版信息

N Engl J Med. 1998 Oct 1;339(14):974-84. doi: 10.1056/NEJM199810013391407.

DOI:10.1056/NEJM199810013391407
PMID:9753714
Abstract
摘要

相似文献

1
Treatment of breast cancer.乳腺癌的治疗。
N Engl J Med. 1998 Oct 1;339(14):974-84. doi: 10.1056/NEJM199810013391407.
2
Metastatic breast cancer.转移性乳腺癌
Aust Fam Physician. 2006 May;35(5):309-12.
3
Chemotherapy in the treatment of advanced breast cancer.
Med J Aust. 1977 Aug 27;2(9):294-6.
4
[Diagnosis and treatment of breast cancer].[乳腺癌的诊断与治疗]
Kurinikaru Sutadi. 1986 Aug;7(8):853-8.
5
[Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].来曲唑与他莫昔芬相比作为绝经后晚期乳腺癌女性一线治疗的优越性：国际来曲唑乳腺癌研究组III期研究结果
Strahlenther Onkol. 2002 Feb;178(2):111-3.
6
Locally advanced and inflammatory breast cancer.局部晚期炎性乳腺癌
Aust Fam Physician. 2005 Dec;34(12):1027-32.
7
The use of chemotherapy in metastatic breast cancer.化疗在转移性乳腺癌中的应用。
Hematol Oncol Clin North Am. 1989 Dec;3(4):807-21.
8
[What therapeutic benefits are there in the early diagnosis of metastases in patients with breast carcinoma?].
Zentralbl Chir. 1992;117(4):231-3.
9
[Therapy of metastasizing breast cancer].
Clin Ter. 1978 Jan 15;84(1):5-26.
10
[Treatment of drug-resistant metastasizing cancer of the breast with an antiestrogen].
Ugeskr Laeger. 1978 Oct 23;140(43):2639-41.

引用本文的文献

1
Chemoinformatics analysis of leaves extracted phytochemicals as potential EGFR kinase modulators.对从树叶中提取的植物化学物质作为潜在表皮生长因子受体（EGFR）激酶调节剂进行化学信息学分析。
Front Chem. 2025 Mar 24;13:1524384. doi: 10.3389/fchem.2025.1524384. eCollection 2025.
2
Effectiveness of Automated Treatment Planning for Left-sided Breast in Flattening Filter-free Photon Beams.无均整器光子束中左侧乳腺自动治疗计划的有效性
J Med Phys. 2024 Oct-Dec;49(4):701-705. doi: 10.4103/jmp.jmp_95_24. Epub 2024 Dec 18.
3
The impact of breast surgery and systemic therapy on the survival of patients with de novo stage IV breast cancer.
乳房手术和全身治疗对初诊IV期乳腺癌患者生存的影响。
Breast Cancer. 2025 Mar;32(2):426-433. doi: 10.1007/s12282-025-01675-w. Epub 2025 Feb 2.
4
Ergosterol inhibits the proliferation of breast cancer cells by suppressing AKT/GSK-3beta/beta-catenin pathway.麦角固醇通过抑制 AKT/GSK-3β/β-连环蛋白通路抑制乳腺癌细胞增殖。
Sci Rep. 2024 Aug 24;14(1):19664. doi: 10.1038/s41598-024-70516-1.
5
Multidisciplinary Treatment for Locally Advanced Mucinous Breast Cancer.局部晚期黏液性乳腺癌的多学科治疗
Case Rep Oncol. 2024 Jul 31;17(1):837-842. doi: 10.1159/000539717. eCollection 2024 Jan-Dec.
6
New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer.具有抗三阴性乳腺癌特性的新型Hsp90 C末端结构域抑制剂
J Med Chem. 2024 Aug 8;67(15):12984-13018. doi: 10.1021/acs.jmedchem.4c00932. Epub 2024 Jul 23.
7
Personalized surgical recommendations and quantitative therapeutic insights for patients with metastatic breast cancer: Insights from deep learning.转移性乳腺癌患者的个性化手术建议和定量治疗见解：深度学习的启示
Cancer Innov. 2024 Apr 15;3(3):e119. doi: 10.1002/cai2.119. eCollection 2024 Jun.
8
Unraveling the anti-breast cancer activity of Cimicifugae rhizoma using biological network pathways and molecular dynamics simulation.利用生物网络途径和分子动力学模拟揭示升麻的抗乳腺癌活性
Mol Divers. 2025 Feb;29(1):241-254. doi: 10.1007/s11030-024-10847-3. Epub 2024 Apr 13.
9
Study on the mechanism of MDSC-platelets and their role in the breast cancer microenvironment.髓源性抑制细胞-血小板的机制及其在乳腺癌微环境中的作用研究。
Front Cell Dev Biol. 2024 Feb 9;12:1310442. doi: 10.3389/fcell.2024.1310442. eCollection 2024.
10
Methylation of promoter induced by SNAI2-DNMT3B complex promotes epithelial-mesenchymal transition and correlates with poor prognosis in ERα-positive breast cancers.由SNAI2-DNMT3B复合物诱导的启动子甲基化促进上皮-间质转化，并与雌激素受体α阳性乳腺癌的不良预后相关。
MedComm (2020). 2023 Oct 24;4(6):e403. doi: 10.1002/mco2.403. eCollection 2023 Dec.